ANTIBIOTHERAPY IN NEUROSURGICAL PATIENTS AS A BLOOD-BRAIN BARRIER CHEATER - IS IT WORTH IT?
DOI:
https://doi.org/10.52692/1857-0011.2024.2-79.44Keywords:
Antibiotherapy, infection, blood-brain barrier, neurosurgeryAbstract
The blood-brain barrier (BBB) is a mandatory mechanism in the vascular dynamic of the central nervous system (CNS). It employs multiple processes to maintain homeostasis. A systematic literature review was conducted, encompassing 65 sources from different databases, that involved studies solely on humans. Potential routes, and barriers to pharmacotherapy were identified and described. In conclusion, antibiotherapy continues to be a relevant topic due to the diverse and sometimes conflicting pharmacodynamic properties exhibited by different antibiotic classes under varying pathological conditions.
References
Tan Q. et al. Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood-brain barrier. Journal of Materials Chemistry B, 2022; 10(45):9314- 9333.
Banks W.A. Characteristics of compounds that cross the blood-brain barrier. BMC Neurology, 2009; 9(1):1-5.
Khawli L.A. et al. Drug delivery across the blood- brain barrier. Molecular Pharmaceutics, 2013; 10(5):1471-1472.
Viscusi E.R. et al. Blood-brain barrier: Mechanisms governing permeability and interaction with peripherally acting μ-opioid receptor antagonists. Regional Anesthesia and Pain Medicine, 2020; 45(9):688–695.
Tamai I. et al. Transporter-mediated permeation of drugs across the blood-brain barrier. Journal of Pharmaceutical Sciences, 2000; 89(11):1371–1388.
Liu L.H. Antibiotic delivery across the blood-brain barrier by nanoparticle system. 2008.
Nau R. et al. Penetration of drugs through the blood- cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clinical Microbiology Reviews, 2010; 23(4):858-883.
Haddad N. et al. The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults. Antibiotics, 2022; 11(12):1-37.
Yuan M. et al. Ceftazidime/avibactam combined with colistimethate sodium successfully cures carbapenem- resistant Pseudomonas aeruginosa-induced brain abscess in a child post-craniotomy: a case report. Frontiers in Oncology, 2024; 14(0):1-8.
Brockner O. et al. Intensive Care Medicine Cefotaxime in Treatment of Meningitis and Ventriculitis? Evaluation of Drug Concentrations in Human Cerebrospinal Fluid. Intensive Care Med, 1982; 8(1):33-38.
Hosmann A. et al. Linezolid brain penetration in neurointensive care patients. Journal of Antimicrobial Chemotherapy, 2024; 79(3):669–677.
Lallani S.B. et al. Use of an Intracranial Drain as a Conduit for Treatment of an Intracranial Streptococcus intermedius Abscess. Cureus, 2021; 13(4):1-6.
Schneider F. et al. Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update. Antibiotics, 2022; 11(2):1-22.
Mrowczynski O.D. et al. Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update. Clinical Neurology and Neurosurgery, 2018; 170(0):140-158.
Chusri S. et al. Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. International Journal of Antimicrobial Agents, 2018; 51(4):646–650.
Hu Y. et al. Intrathecal or intraventricular antimicrobial therapy for post-neurosurgical intracranial infection due to multidrug-resistant and extensively drug- resistant Gram-negative bacteria: A systematic review and meta-analysis. International Journal of Antimicrobial Agents, 2019; 54(5):556-561.
Li C. et al. Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic. Infection and Drug Resistance, 2023; 16(0):3807-3818.
Knoop M. et al. Antibiotic prophylaxis in cerebrospinal fluid shunting: Reassessment of Cefotiam penetration into human CSF. Zentralblatt Fur Neurochirurgie, 2007; 68(1):14–18.
Wang J.F. et al. Blood-brain barrier penetration of cefepime after neurosurgery. Chin Med J (Engl), 2007; 120(13):1176-1178.
Abu Bakar A. et al. An Unusual Case of the Successful Treatment of Carbapenem-resistant Ventriculitis with Intravenous Colistin. Cureus, 2020; 12(2):1-5.
Fuhr U. et al. CSF Pharmacokinetics of Ceftazidime in Neurosurgical Patients with an External Ventriculostorny. Infection, 1989; 17(1):21–22.
McLaurin R.L. Treatment of infected ventricular shunts. Childs Brain, 1975; 1(5):306-310.
Cook A.M. et al. Linezolid for the treatment of a heteroresistant Staphylococcus aureus shunt infection. Pediatric Neurosurgery, 2005; 41(2):102–104.
Nau R. et al. New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections. Antibiotics, 2024; 13(1):1-13.
Wang Q. et al. Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients. Surgical Neurology, 2008; 69(2):126–129.
Guo W. et al. Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis with polymyxin B and tigecycline- a case report. Antimicrobial Resistance and Infection Control, 2018; 7(1):1-4.
Wu P. et al. KHDRBS3 regulates the permeability of blood–tumor barrier via cDENND4C/miR-577 axis. Cell Death and Disease, 2019; 10(7):1-15.
Johanson C. et al. Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Disease More Effectively. CNS & Neurological Disorders - Drug Targets, 2016; 15(9):1151–1180.
Mounier R. et al. Is First-Line Vancomycin Still the Best Option to Treat Staphylococcus Health Care– Associated Meningitis? World Neurosurgery, 2017; 99(0):1-19.
Croitoru D. et al. Surgical site infections in open craniotomy – a narrative literature review. Sănătate Publică, Economie și Management în Medicină, 2024; 101(4):36-40.
Downloads
Published
License
Copyright (c) 2025 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
